Publications by authors named "V Saravanakumar"

Claim this Profile
C
CRISPR editing of HPFH3 genotype induces γ-globin expression and reverses sickle cell disease and β-thalassemia phenotypes.
Sangam Giri Goswami, Pragya Gupta, V R Arvinden, Nupur Bhargava, Aditya Ramdas Iyer, Vinodh Saravanakumar

Stem Cell Res Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Seroprevalence of IgG antibodies against hepatitis-A infection among individuals aged 6-30 years in India, 2021: a nationwide population-based cross-sectional study.
Muthusamy Santhosh Kumar, Chethrapilly Purushothaman Girish Kumar, Velusamy Saravanakumar, Thiyagarajan Karunakaran, Jeromie Wesley Vivian Thangaraj

Lancet Reg Health Southeast Asia· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CRISPR-mediated generation of a tumor-associated antigen-deficient Raji platform to investigate antigen loss in CAR-T cell therapy.
Aditya Ramdas Iyer, Mehwish Nafiz, Pragya Gupta, Arvinden Vr, Vinodh Saravanakumar

Front Genome Ed· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and Functional Validation of Novel Pathogenic Variants in Primary Immunodeficiencies.
Arvinden Vr, Geeta Madathil Govindaraj, Aditya Ramdas Iyer, Sangita Paul, Athulya Edavazhippurath, Vinodh Saravanakumar

Eur J Immunol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CRISPR/Cas9-engineering of Kell null erythrocytes to unveil host targeted irresistible antimalarial.
Geeta Kumari, Pragya Gupta, Sangam G Goswami, Ravi Jain, Sakshi Anand, Vinodh Saravanakumar

Commun Biol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis